10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 252 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $263,548 | -61.8% | 13,550 | -26.3% | 0.00% | 0.0% |
| Q1 2024 | $690,064 | -29.1% | 18,387 | +5.7% | 0.00% | -50.0% |
| Q4 2023 | $973,732 | +34.1% | 17,401 | -1.2% | 0.00% | 0.0% |
| Q3 2023 | $726,309 | -25.0% | 17,608 | +1.5% | 0.00% | -33.3% |
| Q2 2023 | $968,910 | +101462.9% | 17,351 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $954 | +43.2% | 17,139 | -6.2% | 0.00% | +50.0% |
| Q4 2022 | $666 | -99.8% | 18,264 | +28.2% | 0.00% | 0.0% |
| Q3 2022 | $406,000 | -31.1% | 14,245 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $589,000 | -66.4% | 13,006 | +10.6% | 0.00% | -71.4% |
| Q4 2021 | $1,751,000 | -15.5% | 11,758 | -17.4% | 0.01% | -36.4% |
| Q3 2021 | $2,073,000 | -30.2% | 14,243 | -6.1% | 0.01% | -38.9% |
| Q2 2021 | $2,970,000 | – | 15,167 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |